Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 3/20 | 0.93 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.93 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.93 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.93 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.93 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | FABP3 | P05413 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL11791713 | 0.97 | FFAR3 (0.88) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL6387265 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL10908702 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL1331084 | 0.93 | — | — | |
| Butyric Acid SCHEMBL11419652 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL1330878 | 0.93 | — | — | |
| Butyric Acid SCHEMBL11441641 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL4292004 | 0.93 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL2587931 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL9800297 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4215537-B1 | LIGAND COMPOUND, ORGANOCHROMIUM COMPOUND, AND CATALYST SYSTEM COMPRISING THE SAME | LG CHEMICAL LTD (KR) | 2026-04-29 | — | — | EP | claimed |
| EP-4700033-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | claimed |
| EP-4700031-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | claimed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | claimed |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | LG CHEM, LTD. (KR) | 2025-12-18 | — | — | US | claimed |
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | LG CHEM, LTD. (KR) | 2025-10-30 | — | — | US | claimed |
| EP-4559921-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2025-05-28 | — | — | EP | claimed |
| WO-2025106415-A1 | ETHYLENE TRIMERIZATION CATALYST SYSTEMS CONTAINING AROMATIC SOLVENTS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-05-22 | — | — | WO | claimed |
| CN-119836425-A | Ligand compound, organic chromium compound, and catalyst composition comprising same | 株式会社LG化学 | 2025-04-15 | — | — | CN | claimed |
| WO-2000037175-A1 | CATALYST AND PROCESSES FOR OLEFIN TRIMERIZATION | PHILLIPS PETROLEUM COMPANY (US) | 2000-06-29 | — | — | WO | claimed |
| US-5859303-A | OLIGOMERIZATION CATALYST SYSTEM COMPRISES A CHROMIUM SOURCE, A PYRROLE-CONTAINING COMPOUND AND A METAL ALKYL | PHILLIPS PETROLEUM COMPANY (US) | 1999-01-12 | — | — | US | claimed |
| US-5856257-A | USING COORDINATION CATALYST FROM CHROMIUM COMPOUND, A PYRROLE COMPOUND AND METAL ALKYL COMPOUND | PHILLIPS PETROLEUM COMPANY (US) | 1999-01-05 | — | — | US | claimed |
| EP-0780353-A1 | Process for the oligomerisation of olefins | PHILLIPS PETROLEUM COMPANY (US) | 1997-06-25 | — | — | EP | claimed |
| US-5543375-A | STABILIZATION OF OLEFIN OLIGOMERIZATION CATALYST BY REACTING A CHROMIUM COMPOUND, A PYROLE DERIVATIVE AND A METAL ALKYL COMPOUND IN PRESENCE OF UNSATURATED HYDROCARBON, THEN ADDING AN AROMATIC HYDROCARBON | PHILLIPS PETROLEUM COMPANY (US) | 1996-08-06 | — | — | US | claimed |
| EP-0668105-A2 | Olefin production | PHILLIPS PETROLEUM COMPANY (US) | 1995-08-23 | — | — | EP | claimed |
| US-5399539-A | Chromium, pyrrole and aluminum compounds on supports, recovering and activation | PHILLIPS PETROLEUM COMPANY (US) | 1995-03-21 | — | — | US | claimed |
| US-4211882-A | OXIDIZING P-TOLUALDEHYDE, CATALYST CONSISTING OF A MANGANESE COMPOUND, A COBALT COMPOUND, A BROMINE COMPOUND, AND A NICKEL, IRON, CHROMIUM, OR LANTHANIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1980-07-08 | — | — | US | claimed |
| US-4150208-A | CATALYST COMPLEX OF CHROMIUM CARBOXYLATE AND ORGANONITROGEN COMPOUND | CHEMPLEX COMPANY (US) | 1979-04-17 | — | — | US | claimed |
| US-4096093-A | REACTION PRODUCT OF A CHROMIUM CARBOXYLATE WITH AN ORGANIC NITROGEN COMPOUND | CHEMPLEX COMPANY (US) | 1978-06-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | OXER1, ORC3, CRKL | FFAR3 2808/4885HDAC3 2862/4885HDAC1 1049/4885 |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | ADH1A, ADH1C, YAP1 | FFAR3 999/4885HDAC3 4508/4885HDAC1 4496/4885 |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | EXOC1, OXER1, ORC3 | FFAR3 2561/4885HDAC3 3152/4885HDAC1 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.